Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson’s disease
Matthew T. Rocco, Asad S. Akhter, Debra Ehrlich, Gretchen Scott, Codrin Lungu, Vikas Munjal, Anthony Aquino, Russell R. Lonser, Massimo S. Fiandaca, Mark Hallett, John D. Heiss, Krystof S. Bankiewicz
Topics & Concepts
Glial cell line-derived neurotrophic factorPutamenMedicineCannulaMagnetic resonance imagingNuclear medicineNeurotrophic factorsRadiologySurgeryInternal medicineReceptorNeurological disorders and treatmentsNerve injury and regenerationAdvanced MRI Techniques and Applications